Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $103.3400 (3.86%) ($103.3400 - $103.3400) on Tue. Dec. 22, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.89% (three month average) | RSI | 81 | Latest Price | $103.3400(3.86%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1.3% a day on average for past five trading days. | Weekly Trend | LGND advances 7.6% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(56%) IWO(54%) XBI(51%) IWM(50%) IWC(49%) | Factors Impacting LGND price | LGND will decline at least -1.445% in a week (0% probabilities). VIXM(-23%) UUP(-17%) VXX(-15%) UNG(-3%) USO(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.445% (StdDev 2.89%) | Hourly BBV | 2.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $99.79(3.56%) | 10 Day Moving Average | $97.49(6%) | 20 Day Moving Average | $91.89(12.46%) | To recent high | -0.9% | To recent low | 28.6% | Market Cap | $1.661b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |